Volume 1 Issue 4


Special Article-Inflammatory Bowel Disease

Safety Profile of Anti-TNF Agents in Polish Pediatric Patients with Crohn’s Disease

Authors: Edyta Szymanska, Maciej Dadalski, Grzegorz Oracz and Jaroslaw Kierkus

Type: Special Article-Inflammatory Bowel Disease   
  
  

Special Article- Stomach cancer

Clinical Course, Treatment Strategies, Social and Economic Impact of Ulcerative Colitis: An Overview

Authors: Øistein Hovde, Gert Huppertz-Hauss, Marte L Høivik and Bjørn Moum

Type: Special Article- Stomach cancer   
  
  

Mini Review

Current Status and Challenges of Inflammatory Bowel Disease in China

Authors: Yanmin Guo, Xiaomin Sun, Chong He, Wei Wu and Zhanju Liu

Type: Mini Review   
  
  

Special Article- Stomach cancer

Low Virulence of Helicobacter Pylori and Gastric Cancer: the Contribution of Polymorphisms of iNOS and DNA Repair Enzymes in this Process

Authors: Isabelle Joyce de Lima Silva-Fernandes, Ana Paula Santos do Carmo, Débora Menezes da Costa, Emanuele Silva de Oliveira, Eliane dos Santos Pereira and Silvia Helena Barem Rabenhorst

Type: Special Article- Stomach cancer   
  
  

Special Article-Inflammatory Bowel Disease

Analysis of Mucosal Microbiota in Inflammatory Bowel Disease using a Custom Phylogenetic Microarray

Authors: Arun Gupta, Seungha Kang, Josef Wagner, Carl Kirkwood, Mark Morrison, Chris McSweeney and Finlay Macrae

Type: Special Article-Inflammatory Bowel Disease   
  
  

Published Manuscripts

Impact Factor: 2.8

falciform-ligament

 About the Journal  


Austin Journal of Gastroenterology is an open access, peer reviewed, scholarly journal dedicated to publish articles related to original and latest advancement of in the field of Gastroenterology.

The aim of this journal is to provide a platform for research scholars and academicians around the globe to promote, share, and discuss various new issues and developments in different fields of
More>>


Featured Article


Safety Profile of Anti-TNF Agents in Polish Pediatric Patients with Crohn’s Disease

Abstract In recent years, monoclonal antibodies against TNF-alpha, infliximab (IFX) and Adalimumab, have been gaining increasing popularity in Crohn’s disease (CD) management.
More>>


© 2014 Austin Publications LLC